Rethymic Disease Interactions
There is 1 disease interaction with Rethymic (allogeneic processed thymus tissue).
Allogeneic processed thymus tissue (applies to Rethymic) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Renal dysfunction at baseline is considered a risk factor for death when using allogeneic processed thymus tissue. Ensure the involvement of a nephrologist in the care of patients with renal impairment.
Switch to professional interaction data
Rethymic drug interactions
There are 253 drug interactions with Rethymic (allogeneic processed thymus tissue).
Report options
More about Rethymic (allogeneic processed thymus tissue)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: other immunostimulants
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mozobil
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected ...
Xolremdi
Xolremdi is used to treat WHIM syndrome in adults and children 12 years of age and older to ...
Plerixafor
Plerixafor systemic is used for hematopoietic stem cell mobilization, multiple myeloma ...
Mavorixafor
Mavorixafor is used to treat WHIM syndrome (warts, hypogammaglobulinemia, infections, and ...
Glatiramer
Glatiramer acetate (brand name Copaxone, Glatopa, and generics) is used to treat relapsing forms of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.